The drug distributor will buy a majority stake in gastroenterology practice management group GI Alliance and purchase ...

Daniel Grosslight, an analyst from Citi, maintained the Hold rating on Cardinal Health (CAH – Research Report). The associated price ...

Analyst Michael Cherny from Leerink Partners reiterated a Buy rating on Cardinal Health (CAH – Research Report) and keeping the price target at $138.00. Michael Cherny has given his Buy rating due to ...

The health-tech industry’s long-term growth is fueled by the growing need for cutting-edge technologies to address critical ...

Dublin-based wholesale drug distribution and medical supplies company Cardinal Health is spending $3.9 billion on two ...

Cardinal Health plans to buy two companies that will expand its diabetes and gastroenterology businesses as part of an ...

Cardinal Health (NYSE:CAH) to acquire two companies that accelerate strategic growth areas and that will enhance patient care ...

The Vatican has announced that the pope had accepted Franciscan Bishop Paskalis Bruno Syukur of Bogor’s request not to be made a cardinal. On October 6, Pope Francis had announced the creation ...

Use of Non-GAAP MeasuresThis earnings release contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). In addition to ...

Cardinal Health has raised its fiscal year 2025 outlook for adjusted EPS to $7.75-$7.90 from $7.55-$7.70 versus consensus of $7.63. The company updated expectations for its adjusted free cash flow ...